Moizerto ointment 1% for atopic dermatitis (difamilast, anti-inflammatory)

What is Moizerto ointment 1% for atopic dermatitis (difamilast, anti-inflammatory)?

Experience the transformative relief and effectiveness of Moizerto Ointment 1% in managing atopic dermatitis. This powerful ointment is expertly crafted with difamilast, a cutting-edge active ingredient designed to provide potent relief and healing for atopic dermatitis. With its unique mechanism targeting the underlying causes of inflammation, Moizerto ointment is your reliable ally in achieving healthier, clearer skin.

Unmatched Relief with Difamilast

Moizerto Ointment leverages the efficacy of difamilast to deliver outstanding results in atopic dermatitis treatment. Difamilast functions by inhibiting the enzyme phosphodiesterase 4 (PDE4), crucial in the skin’s inflammatory processes. By modulating the expression of inflammatory and anti-inflammatory agents within cells, this ointment offers swift and enduring relief from itching and inflammation.

Quick Onset of Action

One of the key highlights of Moizerto Ointment is its rapid onset of action. Users typically observe significant symptom improvement within just one week of initiating treatment, making Moizerto an excellent choice for those in need of prompt and effective relief from atopic dermatitis discomfort.

Verified Effectiveness

Moizerto Ointment’s effectiveness is supported by comprehensive scientific research. A significant study titled “Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study” confirmed that difamilast is safe and well-tolerated, even over long-term use. Participants in the study showed considerable improvements in the Eczema Area and Severity Index (EASI) and Investigator's Global Assessment (IGA) scores over a 52-week treatment period.

Suitable for All Ages

Approved for use in both adults and children as young as two years old, Moizerto Ointment is a versatile solution for families dealing with atopic dermatitis. This ointment is gentle yet highly effective, ensuring that patients of all ages can benefit from its therapeutic properties.

Why Choose Moizerto Ointment?

• Targeted Action: Moizerto’s difamilast-based formula specifically addresses the inflammatory processes of atopic dermatitis.
• Fast Relief: Significant symptom improvement is typically seen within one week of use.
• Scientifically Proven: Supported by extensive research affirming its safety and efficacy.
• Versatile Use: Suitable for both adults and children aged two years and older.

In summary, Moizerto Ointment 1% stands out as a premier choice for atopic dermatitis treatment. Its innovative formulation, rapid action, and proven efficacy make it an ideal option for those seeking relief from the challenges of atopic dermatitis. Embrace the benefits of Moizerto and take a confident step towards healthier, irritation-free skin today.

For those in search of a dependable and effective atopic dermatitis cream or ointment, Moizerto Ointment 1% is the solution you need.

Active principles: difamilast

Amount: 10 tubes * 10 g

Indications: Store in a dry cool place, out of reach of children. Do not use for pregnant or breastfeeding women. Female patients should avoid pregnancy not only while using this medicine, but also for a certain period of time after its completion. Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use.

How to use: apply an appropriate amount of this medicine to the affected area twice a day. An average dosage for two palms-size eruption of an adult is 2.5 cm of ointment (from the tip of an adult forefinger to its first joint) squeezed out from the tube. 

Wash your hands thoroughly before and after applying. Avoid the infected skin area during application. Do not apply this medicine to mucosa, ulcer or erosion clearly formed plaque. Strictly avoid getting this medicine into the eyes.

Contraindications and precautions: Store in a dry cool place, out of reach of children. Do not use for pregnant or breastfeeding women. Female patients should avoid pregnancy not only while using this medicine, but also for a certain period of time after its completion. Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use.